Revista de la Facultad de Medicina Humana (Jul 2022)

Clinical implications of the molecular biology of prostate cancer: Review article

  • María del Carmen Castro-Mujica

DOI
https://doi.org/10.25176/RFMH.v22i3.5043
Journal volume & issue
Vol. 22, no. 3
pp. 589 – 605

Abstract

Read online

To understand the term genomic heterogeneity in prostate cancer, we must understand the clonal genomic evolution of cancer, as well as knowing that it is a dynamic and evolutionary phenomenon. Knowing the genome of prostate cancer not only allows us to have a vision over time of the genomic alterations that occur during its different stages, but also to learn about the mechanisms of metastasis. In addition, knowing the hereditary component of prostate cancer allows the evaluation of patients and to be able to identify if we are dealing with a family at risk.

Keywords